Serum uric Acid is not an independent risk factor for premature coronary artery disease

Sara Zand1, Akbar Shafiee1, Mohammadali Boroumand1

  • 1Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.

Cardiorenal Medicine
|January 30, 2014
PubMed

Insights

Serum uric acid is not an independent risk factor for premature coronary artery disease (CAD). While weakly correlated with disease extent, further research is needed to clarify its role in cardiovascular health.

Area of Science:

  • Cardiology
  • Biochemistry

Background:

  • Debate exists regarding serum uric acid's role as an independent risk factor for coronary artery disease (CAD), especially premature CAD.
  • Understanding novel risk factors is crucial for cardiovascular disease prevention.

Purpose of the Study:

  • To investigate serum uric acid as a risk factor for premature CAD.
  • To determine if serum uric acid influences the severity of coronary artery stenosis.

Main Methods:

  • Study included candidates for coronary angiography under 45 (men) and 55 (women).
  • Clinical data and serum uric acid levels were compared between premature CAD patients and controls.
  • Statistical analysis adjusted for confounding variables, including established CAD risk factors.

Main Results:

  • Serum uric acid showed a significant relationship with CAD presence, but this was not independent after adjusting for confounders.
  • No significant difference in uric acid levels was found across different severities of coronary artery stenosis.
  • Adjusted analyses confirmed uric acid's lack of significant association with CAD extent.

Conclusions:

  • Serum uric acid is not an independent risk factor for premature CAD.
  • A weak correlation between uric acid and CAD extent was observed, warranting further investigation.
  • Current findings suggest uric acid's role in premature CAD is not as a primary independent risk factor.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
973
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765